Explore the full insider trade history of 듀켐바이오, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 듀켐바이오 has published 39 insider filings. The latest transaction was disclosed on 27 December 2024 (Purchase). Among the most active insiders: 김종우. The full history is accessible without an account.
39
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
1 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.